Abstract
Normal pattern of parathyroid response to subsequent induction of calcium lowering and raising has been shown in most patients with surgical hypoparathyroidism and in patients with primary hyperparathyroidism. The relationship of S-PTH to B-Ca2+ showed in hypoparathyroid patients with residual PTSH_capacity, an inverse sigmoidal relationship, displaced downwards and to the left, as compared with controls. Whereas, the curve of untreated patients with primary hyperparathyroidism was displaced upwards and to the right, exhibiting significantly raised values for PTH maximum, PTH minimum and Brown's calcium set-point, Furthermore, the slope of the sigmoidal curve in patients with primary hyperparathyroidism was significantly less than in normal humans, which may reflect a reduced sensitivity of parathyroid adenomas to B-Ca2+. The calcium set-points are raised in primary hyperparathyroidism and return to normal following parathyroidectomy. The values for Brown's and Parfitt's calcium set-points are significantly different, but strikingly well correlated, supporting the view that Brown and Parfitt describe two different points on the same sigmoidal curve, corresponding to 50% and about 85% inhibition of PTH maximum, respectively.
Similar content being viewed by others
References
Payne RB, Jones DP, Walker AP et al.: Clustering of serum calcium and magnesium concentrations in siblings. Clin Chem 32: 349–350, 1986
Boucher A, D'Amour P, Hamel L et al.: Estrogen replacement decreases the set point of parathyroid hormone stimulation by calcium in normal postmenopausal women. J Clin Endocrinol Metab 68: 831–836, 1989
Brent GA, LeBoff MS, Seely EW et al.: Relationship between the concentration and rate of change of calcium and serum intact parathyroid hormone levels in normal humans. J Clin Endocrinol Metab 68: 944–950, 1988
Gardin JP, Patron P, Fouqueray B et al.: Maximal PTH secretory rate and setpoint for calcium in normal subjects and patients with primary hyperparathyroidism (in vivo sttdies). Miner Electro Metab 14: 221–228, 1988
Grant FD, Conlin PR, Brown EM: Rate and concentration dependence of parathyroid hormone dynamics during stepwise changes in serum ionized calcium in normal humans. J Clin Endocrinol Metabol 71: 370–380, 1990
Schwarz P, Sorensen HA, McNair P et al.: Cicaclamp technique; a method for quantifying parathyroid hormone secretion: a sequential citrate and calcium clamp study. Eur J Clin Invest 23: 546–553, 1993
Segre GV, Harris ST, Neer R et al.: Sigmoidal relationship between plasma parathyroid hormone and calcium concentration in man. 3'rd Annual Scientific Meeting in the American Society of Bone and Mineral Research, Cincinnati 30A, 1981
Brown EM, Broadus AE, Brennan MF et al.: Direct comparison in vivo and in vitro of suppressibility of parathyroid function by calcium in primary hyperparathyrodism. J Clin Endocrinol Metab 48: 604–610, 1979a
Brown EM, Leboff MS, Oetting M et al.: Secretory control in normal and abnormal parathyroid tissue. Rec Prog Horm Res 43: 337–382, 1987
Blind E, Schmidt-Gayk H, Scarla S et al.: Two-site assay of intact parathyroid hormone in the investigation of primary hypoparathyroidism and other disorders of calcium metabolism compared with a midregion assay. J Clin Endocrinol Metab 67: 353–360, 1988
Rudnicki M, McNair P, Transbb I et al.: Diagnostic applicability of intact and midregion/C-terminal parathyroid hormone assays in calcium metabolic disorders. J Intern Med 228: 465–470, 1990
Schwarz P, Hyldstrup L, Transbøl I: Cica-clamp evaluation of parathyroid responsiveness in chronic hypoparathyroidism. Miner Electro Metab 1994 (in press)
Rudnicki M, Transbøl I: Residual parathyroid function in chronic surgical hypoparathyroidism. Miner Electro Metab 17: 331–334, 1991
Brown EM: Four-parameter model of the sigmoidal relationship between parathyroid hormone release and extracellular calcium concentration in normal and abnormal parathyroid tissue. J Clin Endocrinol Metab 56: 572–581, 1983
Åkerström G, Malmaeus J, Bergström R: Surgical anatomy of human parathyroid glands. Surg 95: 15–21, 1984
Tibblin S, Bizard JP, Bondeson A-G et al.: Primary hyperparathyroidism due to solitary adenoma. Eur J Surg 157: 511–515, 1991
Benson L, Rastad J, Wide L et al.: Stimulation of parathyroid hormone secretion by EDTA infusion — a test for the differential diagnosis of hypercalcaemia. Acta Endocrinol 111: 498–506, 1986
Benson L, Wide L, Åkerström G et al.: A stimulation test with calcitonin for differential diagnosis of hypercalcaemia. Acta Endocrinol 107: 237–244, 1984
Lips P, Netelenbos JC, van Doorn L et al.: Stimulation and suppression of intact parathyroid hormone (PTH (1-84)) in normal subjects and hyperparathyroid patients. Clin Endocrinol 35: 35–40, 1991
Ljunghall S, Benson L, Rastad J et al.: Dynamic tests of parathyroid function for diagnosis of primary hyperparathyroidism in malignancy. Clin Endocrinol 27: 163–170, 1987
Mazzuoli G, Minisola S, Scarnecchia L et al.: Two-site assay of intact parathyroid hormone in primary hyperparathyroidism: studies in basal conditions, following adenoma removal and during calcium and EDTA infusion. Clin Chim Acta 190: 239–248, 1990
Murray TM, Peacock M, Powell D et al.: Nonautonomy of hormone secretion in primary hyperp arathyroidism. Clin Endocrinol 1: 235–246, 1972
Paillard M, Gardin JP, Borensztein P et al.: Determination of parathormone secretion in primary hyperparathyroidism. Horm Research 32: 89–92, 1989
Reiss E, Canterbury JM: Primary hyperparathyroidism. N Engl J Med 280: 1381–1385, 1969
Sørensen HA, Schwarz P, McNair P et al.: Calcium clamp technique: Suppression of serum intact PTH by induced hypercalcaemia in normal man and primary hyperparathyroidism. Scand J Clin Lab Invest 52: 457–465, 1992
Brown EM, Wilson RE, Thatcher JG et al.: Abnormal calcium-regulated PTH release in normal parathyroid tissue from patients with adenoma. Am J Med 71: 565–570, 1981
Parfitt AM, Willgoss D, Jacobi J et al.: Cell kinetics in parathyroidadenomas: Evidence for decline in rates of cell birth and tumour growth, assuming clonal origin. Clin Endocrinol 35: 151–157, 1991
Parfitt AM: The Actions of parathyroid hormone on bone. Relation to bone remodelling and turnover, calcium homeostasis and metabolic bone disease. II. PTH and bone cells: bone turnover and plasma calcium regulation. Metabolism 25: 909–955, 1976
Parfitt AM: Equilibrium and disequilibrium hypercalcemia: new light on an old concept. Metab Bone Dis Relat Res 1: 279–293, 1979
Parfitt AM: Hypercalcemic hyperparathyroidism following renal transplantation: Differential diagnosis, management, and implications for cell population control in the parathyroid gland. Mineral Electrolyte Metab 8: 92–119, 1982
Brown EM: Mechanisms underlying the regulation of parathyroid hormone secretion in vivo and in vitro. Curr Opin Nephrol Hypertens 2: 541–551, 1993
Schwarz P, Sørensen HA, Transbøl I: Interrelations between calcium set-points of Parfitt and Brown in primary hyperparathyroidism. Eur J Clin Invest 24: 553–558, 1994
Brown EM, Gardner DG, Brennan MF et al.: Calcium-regulated parathyroid hormone release in primary hyperparathyroidism. Studies in vitro with dispersed parathyroid cells. Am J Med 66: 928–931, 1978b
Author information
Authors and Affiliations
About this article
Cite this article
Schwarz, P., Madsen, J.C. Parathyroid hormone dynamics in hypoparathyroidism and primary hyperparathyroidism. J Bone Miner Metab 12 (Suppl 1), S75–S79 (1994). https://doi.org/10.1007/BF02375680
Issue Date:
DOI: https://doi.org/10.1007/BF02375680